Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Open, Non Randomized, Phase Ib / IIA Study to Evaluate the Safety and Preliminary Efficacy of AL8326 in the Treatment of Small Cell Lung Cancer

NCT04890795 is registered in ClinicalTrials.gov with Advenchen Laboratories Nanjing Ltd. as lead sponsor.

NCT NCT04890795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04890795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Open, Non Randomized, Phase Ib / IIA Study to Evaluate the Safety and Preliminary Efficacy of AL8326 in the Treatment of Small Cell Lung Cancer
Lead sponsor
Advenchen Laboratories Nanjing Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 19, 2020
Completion date
September 30, 2021
Enrollment
237 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer